期刊文献+

化疗药敏试验的研究现状 被引量:3

Research actuality of chemosensitivity testing in chemotherapy
原文传递
导出
摘要 本文从发展历史、具体方法、临床应用3个方面阐述化疗药敏试验的研究现状。化疗药敏试验是实现肿瘤患者个体化治疗的重要途径,历经60余年,发展为体内法、体外法两大类共10多种方法。药敏试验的基本步骤包括原代肿瘤细胞培养、化疗药混合、反应物混合、观察指标检测和结果分析。本文重点介绍裸鼠肾包膜下人癌模型法、区别染色细胞法、四氮唑盐比色法、三磷酸腺苷一生物荧光肿瘤药敏检测技术、胶原凝胶包埋培养法、靶向分子敏感性测定法6种实验方法的基本原理、主要步骤和特点。通过几个临床试验的结果可以看出,药敏试验指导下的化疗在有效率、中位无进展生存时间、生存期、临床完全缓解率、病理完全缓解率等方面与经验化疗相比有显著改善。 This paper explains the research status of chemotherapy sensitivity test in three aspects of history of development, specific methods and clinical application. Chemotherapy sensitivity test is an important way to achieve individual treatment of cancer, after more than 60 years, there are two major categories ( in vivo method and in vitro method) of more than 10 kinds of methods. The basic steps of sensitivity test include culture of primary tumor cells, chemotherapy drugs mixed, the reaction mixture, observing the results of detection and analysis of indicators. This paper focuses on basic principles, main steps and characteristics of six methods, such as the renal capsule of nude mice model of human cancer, the difference between staining cell, tetrazolium salt colorimetric, adenosine triphosphate based bioluminescence tumor chemosensitivity assay, collagen gel embedded culture method and targeting molecule sensitivity assay. Through the results of several clinical trials,, it can be seen that chemotherapy under the guidance of drug sensitivity test significantly improved more than experience chemotherapy in efficient rate, median progression-free survival time, survival time, clinical complete remission rate, pathological complete remission rate, etc.
出处 《国际外科学杂志》 2009年第8期565-568,共4页 International Journal of Surgery
关键词 药敏试验 肿瘤 化疗 chemosensitivity test tumor chemotherapy
  • 相关文献

参考文献8

  • 1李雯.抗肿瘤药物敏感试验的研究进展[J].中国医院用药评价与分析,2004,4(1):60-61. 被引量:3
  • 2杨英(综述),凌扬(审校),徐建忠(审校).三磷酸腺苷-肿瘤药物敏感法在肿瘤个体化化疗中的应用[J].国际肿瘤学杂志,2008,35(7):491-493. 被引量:2
  • 3Kurbaeher CM, Cree IA. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements [J]. Methods Mol Med, 2005, 110 : 101-120.
  • 4Ugurel S, Schadendorf D, Pfohler C, et al. In vitro drug sensitivity predicts response and survival after individualized sensitivity - directed chemotherapy in metastatic melanoma:a muhicenter phase Ⅱ trial of the Dermatologic Cooperative Oncology Group [ J]. Clin Cancer Res, 2006, 12 ( 18 ) :5454-5463.
  • 5李治,刘春萍,明洁,田元,黄韬.复发性乳腺癌化疗药物敏感性的体外实验[J].肿瘤防治研究,2008,35(2):132-133. 被引量:2
  • 6Kurbacher CM, Crecu OM, Stier U, et al. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials[ J ]. Recent Results Cancer Res, 2003, 16( 1 ) :221-230.
  • 7Cree IA, Kurbacher CM, Lamont A, et al. A prospective randomized controlled trial of tumor chemosensitivity assay directed chemotherapy versus physician' s choice in patients with recurrent p!ati- num resistant ovarian cancer[ J]. Anticancer Drugs, 2007, 18 (9) : 1093-1101.
  • 8Lau GI, too WT, Chow LW. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response [ J ]. Biomed Pharmacother, 2007, 61 (9) :562-565.

二级参考文献23

  • 1张毅,沈炜明.MTT肿瘤药敏试验中培养基的选择[J].药学服务与研究,2004,4(3):269-271. 被引量:22
  • 2Mathieu A, Remmelink M, D'Haene N, et al. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice : analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine de- carboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha ( GST)-alpha, GST-mu, and GST-pi. Cancer, 2004 , 101(8) :1908-1918.
  • 3Mercer SJ, Somers SS, Knight LA, et al. Heterogeneity of chemosensitivity of esophageal and gastric carcinoma. Anticancer Drugs, 2003, 14(6) :397-403.
  • 4Kurbacher CM Cree IA. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements. Methods Mol Med, 2005, 110:101-120.
  • 5Cree IA. Chemosensitivity testing as an aid to anti-cancer drug and regimen development. Recent Results Cancer Res, 2003, 161 : 119- 125.
  • 6Di Nicolantonio F, Neale M, Onadim Z, et al. The chemosensitivity profile of retinoblastoma. Recent Results Cancer Res, 2003, 161:73- 80.
  • 7Ugurel S, Tilgen W, Reinhold U. Chemosensitivity testing in malignant melanoma. Recent Results Cancer Res, 2003, 161:81-92.
  • 8Ugurel S, Schadendorf D, Pfohler C, et al. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a muhicenter phase Ⅱ trial of the Dermatologic Cooperative Oncology Group. Clin Cancer Res, 2006, 12(18) :5454-5463.
  • 9Whitehouse PA, Knight LA, Di Nicolantonio F, et al. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Anticancer Drugs, 2003, 14 (5) :369-375.
  • 10Whitehouse PA, Mercer SJ, Knight LA, et al. Combination chemotherapy in advanced gastrointestinal cancers:ex vivo sensitivity to gemcitabine and mitomycin C. Br J Cancer, 2003, 89 (12) :2299-2304.

共引文献4

同被引文献17

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部